This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove category pharmaceuticals
Remove 2008 Remove FDA Related Topics
Federal Policy Fraud Governance Informed Consent Health Services Administration Public Health World Health Licensing Compliance Prescription Drug Pricing More Related Topics >
article thumbnail

Not the Best Wisconsin Law Decision We’ve Ever Seen

Drug & Device Law

APRIL 18, 2022

The Wisconsin guest post let us know about a pending decision that – we all hoped – would take that state out of the “no state appellate precedent” category altogether: Wisconsin has recently made it to the red zone, and may soon cross the goal line, with the Wisconsin Court of Appeals’ forthcoming decision in Rennick v. 2008); Herzog v.

FDA 59
FDA 59
article thumbnail

Logical Contradiction Doctrine:  Buckman for Textualists

Drug & Device Law

JANUARY 30, 2023

440 (2008) Buckman was not cited at all in the Merck Sharp & Dohme Corp. 440 (2008) Buckman was not cited at all in the Merck Sharp & Dohme Corp. 2019), or Mutual Pharmaceutical Co. Plaintiffs Legal Committee , 531 U.S. Kent , 552 U.S. Kent , 552 U.S. Albrecht , 139 S. Bartlett , 570 U.S. Levine , 555 U.S.

FDA 72
FDA Fraud Governance Medicare 72
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024